Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 11
1998 10
1999 8
2000 22
2001 8
2002 14
2003 13
2004 23
2005 28
2006 38
2007 63
2008 61
2009 89
2010 128
2011 174
2012 247
2013 312
2014 428
2015 503
2016 647
2017 880
2018 1105
2019 1344
2020 1634
2021 2106
2022 2280
2023 2262
2024 2618
2025 1557

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16,237 results

Results by year

Filters applied: . Clear all
Page 1
Comparative efficacy and safety of daridorexant, lemborexant, and suvorexant for insomnia: a systematic review and network meta-analysis.
Kishi T, Ikuta T, Citrome L, Sakuma K, Hatano M, Hamanaka S, Nishii Y, Iwata N. Kishi T, et al. Transl Psychiatry. 2025 Jun 24;15(1):211. doi: 10.1038/s41398-025-03439-8. Transl Psychiatry. 2025. PMID: 40555730
BACKGROUND: In order to appraise the risk-benefit balance of the three available dual orexin receptor antagonists (DORAs; daridorexant, lemborexant, and suvorexant) for the management of adults with insomnia, we conducted a systematic review and random-effects model network …
BACKGROUND: In order to appraise the risk-benefit balance of the three available dual orexin receptor antagonists (DORAs; daridorexant, lemb …
Effects of different art therapy interventions on cognitive functions in older adults: A systematic review and network meta-analysis.
Yue W, Chen Y, Ma X. Yue W, et al. Geriatr Nurs. 2025 Jun 18;64:103392. doi: 10.1016/j.gerinurse.2025.103392. Online ahead of print. Geriatr Nurs. 2025. PMID: 40554229
METHODS: This study included 38 studies and 2,869 patients, using Review manager 5.4 and Stata 17 for statistical analyses. RESULTS: In terms of MMSE scores, music therapy, horticultural therapy, drawing therapy, and creative arts therapy showed significant improvements co …
METHODS: This study included 38 studies and 2,869 patients, using Review manager 5.4 and Stata 17 for statistical analyses. RESULTS: …
Contribution of activated complements and CD59 to the pathophysiology of Rasmussen syndrome.
Takahashi Y, Nishimura S, Takao E, Kasai R, Fukuoka M, Yamaguchi T, Araki Y, Yonee C, Kawano O, Kondo Y, Saito N, Higashijima T, Kuroha Y, Watanabe K, Yano T, Kashii H, Ogawa K, Maeda K, Abe M, Nakamura M, Himeno Y, Hayashi N, Kobayashi O, Fukumura S, Okumura Y, Miyamoto Y, Mogami Y. Takahashi Y, et al. J Neuroimmunol. 2025 Jun 13;406:578667. doi: 10.1016/j.jneuroim.2025.578667. Online ahead of print. J Neuroimmunol. 2025. PMID: 40554195
We expect to unveil complex immunological pathophysiology from the viewpoint of complements to establish newer immunomodulatory treatments. We examined CSF levels of activated complements (iC3b, C5a and soluble membrane attack complex (sMAC)) and CD59 (inhibitor of MAC) us …
We expect to unveil complex immunological pathophysiology from the viewpoint of complements to establish newer immunomodulatory treatment …
Comparative effectiveness of GLP-1 receptor agonists in patients with heart failure with preserved or minimally reduced ejection fraction: a comprehensive Bayesian network meta-analysis and network meta-regression.
Khalil I, Islam MR, Kamrul-Hasan ABM, Nagendra L, Promi SA, Sayed MA, Rahman MT, Sultana N, Tasmi NA, Das M, Tarannum S, Dey R, Dutta D. Khalil I, et al. Endocr Pract. 2025 Jun 17:S1530-891X(25)00919-X. doi: 10.1016/j.eprac.2025.06.005. Online ahead of print. Endocr Pract. 2025. PMID: 40553959
OBJECTIVES: GLP-1 receptor agonists (GLP-1 RAs) have shown beneficial effects on clinical outcomes in patients with heart failure (HF) with preserved ejection fraction (HFpEF) or minimally reduced ejection fraction (HFmrEF). This network meta-analysis (NMA) a …
OBJECTIVES: GLP-1 receptor agonists (GLP-1 RAs) have shown beneficial effects on clinical outcomes in patients with heart failure (HF) with …
Exploring the Role of Left Atrial Fibrosis and Left Atrial Volume Index Through Cardiac Magnetic Resonance Imaging in Embolic Stroke of Undetermined Source: A Network Meta-Analysis.
Immanuel SS, Tandecxi G, Rinaldi FX, Sayogo Y, Sunjaya A, Faustine G, Sunardi AEP, Posangi I, Bandana V. Immanuel SS, et al. Indian Heart J. 2025 Jun 17:S0019-4832(25)00133-6. doi: 10.1016/j.ihj.2025.06.006. Online ahead of print. Indian Heart J. 2025. PMID: 40553785
We performed a Bayesian network meta-analysis to estimate mean differences (MD) with 95% credible intervals (CrI). Node-splitting tested consistency, and a meta-regression examined the effect of age. RESULTS: Ten observational studies wit …
We performed a Bayesian network meta-analysis to estimate mean differences (MD) with 95% credible intervals (CrI …
Efficacy and safety of first-line treatments for recurrent or metastatic nasopharyngeal carcinoma: a systematic review and network meta-analysis.
Cai T, Lin C, Li Q, Mo J, Zheng J, Zhou J. Cai T, et al. Front Immunol. 2025 Jun 9;16:1485609. doi: 10.3389/fimmu.2025.1485609. eCollection 2025. Front Immunol. 2025. PMID: 40552283 Free PMC article.
Then, we conducted a Bayesian network meta-analysis and systematic review of RCTs that met the specified inclusion criteria. ...CONCLUSIONS: Systematic reviews and network meta-analyses integrate evidence from multiple studi …
Then, we conducted a Bayesian network meta-analysis and systematic review of RCTs that met the specified inclusi …
Efficacy and safety of immunotherapy or antiangiogenic agent-based treatment strategies versus chemotherapy as first-line treatment for extensive-stage small cell lung cancer: a network meta-analysis.
Wang C, Yang C, Zhao W, Zhang R, Xuan T, Li J. Wang C, et al. Front Pharmacol. 2025 Jun 9;16:1539246. doi: 10.3389/fphar.2025.1539246. eCollection 2025. Front Pharmacol. 2025. PMID: 40552156 Free PMC article.
Despite the potential of antiangiogenic agents to enhance treatment efficacy, the optimal combination pattern remains unclear. This meta-analysis explores existing treatment strategies involving ICIs or antiangiogenic agents in ES-SCLC. ...The antiangi …
Despite the potential of antiangiogenic agents to enhance treatment efficacy, the optimal combination pattern remains unclear. This …
Lenalidomide, ixazomib, or daratumumab maintenance therapy in multiple myeloma.
Lai E, Soon YY, Lee ARYB, Wong SY, Soekojo CY, Ooi M, Chng WJ, de Mel S. Lai E, et al. Blood Neoplasia. 2024 Sep 16;1(4):100042. doi: 10.1016/j.bneo.2024.100042. eCollection 2024 Dec. Blood Neoplasia. 2024. PMID: 40552136 Free PMC article.
Lenalidomide, ixazomib, and daratumumab have been proposed as maintenance therapies for patients with newly diagnosed multiple myeloma (MM; NDMM). There are, however, no randomized controlled trials (RCTs) comparing them. We conducted a network meta-analys …
Lenalidomide, ixazomib, and daratumumab have been proposed as maintenance therapies for patients with newly diagnosed multiple myelom …
16,237 results
You have reached the last available page of results. Please see the User Guide for more information.